ERBB2 and breast carcinoma: According to the expression of hormone receptors, human epidermal growth factor receptor 2 (HER2) and Ki-67, the intrinsic molecular subtypes of breast cancer have been defined and characterized as HER2-enriched, luminal A, luminal B and triple-negative breast cancer (TNBC).